R

Redhill Biopharma Ltd
D

RDHL

1.08000
USD
-0.11
(-9.24%)
مفتوح الان
حجم التداول
1,150
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
2,478,973
أصول ذات صلة
A
AKRO
-0.040
(-0.08%)
50.330 USD
A
ALLO
-0.01000
(-0.95%)
1.04500 USD
D
DRRX
-0.02500
(-1.32%)
1.86500 USD
G
GNFT
0.01000
(0.27%)
3.76000 USD
I
IMUX
-0.02160
(-2.39%)
0.88090 USD
K
KALA
-0.01000
(-0.14%)
7.19000 USD
R
RCKT
-0.17000
(-5.48%)
2.93000 USD
S
SNGX
-0.13500
(-4.12%)
3.14000 USD
المزيد
الأخبار المقالات

العنوان: Redhill Biopharma Ltd

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-relatedproducts in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.